Excess risk of bleeding in patients with venous thromboembolism on direct oral anticoagulants during initial and extended treatment versus population controls
Journal of Internal Medicine · 2025
DOI: 10.1111/joim.20067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Internal Medicine, 2025. Verfasst von Katarina Glise Sandblad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Venous Thromboembolism, Hemorrhage, Anticoagulants. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Vetenskapsrådet, Göteborgs Läkaresällskap, Hjärt-Lungfonden.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background
The risk of major bleeding from anticoagulant treatment is influenced by both the treatment and the patient's baseline risk, which is often disregarded.
Objectives
To determine the excess bleeding risk in venous thromboembolism (VTE) cases during initial (0 to 6 months) and extended (6 months to 5 years) treatment compared to matched population controls without VTE or anticoagulant treatment, overall, and stratified by sex and age.
Methods
Cancer‐free patients with VTE treated with direct oral anticoagulants from 2014 to 2020, along with propensity score–matched controls, were identified from nationwide Swedish registers. Excess risk of major bleeding was assessed using the incidence rate difference (IRD) calculated by subtracting the control bleeding rate from the case bleeding rate.
Results
The matched cohort comprised 36,115 VTE cases and 36,115 controls. During initial treatment, 388 VTE cases (1.07%) and 103 controls (0.29%) experienced bleeding, IRD: 2.19 (95% confidence interval 1.89–2.49) per 100 person‐years. Following rematching at 6 months, 139 cases (0.70%) and 214 controls (1.08%) experienced bleeding, IRD: 0.70 (0.52–0.89). During initial treatment, females had a higher excess bleeding risk than males, with male IRD: 1.73 (1.34–2.12) and female IRD: 2.69 (2.23–3.15). Excess bleeding risk was highest in the oldest patient population. In extended treatment, excess bleeding was not dependent on sex—male IRD: 0.60 (0.35–0.85), female IRD: 0.81 (0.54–1.08)—and did not increase with age.
Conclusion
The excess bleeding risk from anticoagulant treatment was high during initial treatment, particularly among females and the elderly, but lower and not influenced by sex or age during extended treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Medicine, Geriatrics and Emergency Medicine, Region Västra Götaland, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden.
- Department of Medicine and Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada.
- Department of Medicine, Region Västra Götaland, Sahlgrenska University Hospital/Mölndal, Gothenburg, Sweden.
- Department of Anaesthesiology and Intensive Care, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Anaesthesiology and Intensive Care, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
ORCID-Profile: Katarina Glise Sandblad, Sam Schulman
Förderung
- Vetenskapsrådet
- Göteborgs Läkaresällskap
- Hjärt-Lungfonden
- The Swedish state under the agreement between the Swedish government and the county councils
- Sahlgrenska University Hospitals Research Foundations
- Emelle Funds
- Elsa and Gustav Lindh's foundation
Zitieren
APA
Glise Sandblad, K., Rosengren, A., Schulman, S., Roupe, M., Sandström, T. Z., Philipson, J., Svennerholm, K., & Tavoly, M. (2025). Excess risk of bleeding in patients with venous thromboembolism on direct oral anticoagulants during initial and extended treatment versus population controls. Journal of Internal Medicine. https://doi.org/10.1111/joim.20067
Vancouver
Glise Sandblad K, Rosengren A, Schulman S, Roupe M, Sandström TZ, Philipson J, et al. Excess risk of bleeding in patients with venous thromboembolism on direct oral anticoagulants during initial and extended treatment versus population controls. Journal of Internal Medicine. 2025. doi:10.1111/joim.20067
BibTeX
@article{GliseSandblad2025,
author = {Glise Sandblad, Katarina and Rosengren, Annika and Schulman, Sam and Roupe, Maria and Sandström, Tatiana Zverkova and Philipson, Jacob and Svennerholm, Kristina and Tavoly, Mazdak},
title = {Excess risk of bleeding in patients with venous thromboembolism on direct oral anticoagulants during initial and extended treatment versus population controls},
journal = {Journal of Internal Medicine},
year = {2025},
doi = {10.1111/joim.20067}
}
EUVIMED